BIOLINERX
RSS
RSS
| Careers | Contact Us
search

Investor relations home

BioLineRx is a clinical-stage, publicly-traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel.
The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.

BioLineRx's close ties with universities, research institutes, academic institutions, technology transfer offices and biotech... More >>

Therapeutic pipeline
Title
Download Documentation Pipeline
Upcoming events
DateTitle
12/06/14 5:30 p.m.
through
12/09/14 PT
BioLineRx to present at the 56th ASH Annual Meeting and Exposition December 6 - 9, 2014 in San Francisco, CA
01/12/15
BioLineRx to attend the JP Morgan Financial 33rd Annual Healthcare Investor Conference in San Francisco, CA, to be held during week of January 12, 2015
01/12/15
through
01/14/15
BioLineRx to present at Biotech Showcase January 12-14, 2015
What's new
DateTitle
11/11/14
Download Documentation BioLineRx Company presentation
11/10/14
Download Documentation Third Quarter 2014 Earnings Presentation
Get help downloading or viewing the above file types